Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex
- PMID: 16931204
- DOI: 10.1053/j.ajkd.2006.05.018
Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex
Abstract
A 19-year old patient with tuberous sclerosis presented with a renal angiomyolipoma. Because animal trials of tuberous sclerosis showed an effect of rapamycin on renal tumors, our patient was administered rapamycin for 6 months. During this time, the renal angiomyolipoma shrank significantly, regrew during an 8-month period, and decreased in size again after readministration of rapamycin.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
